Gypenosides improves nonalcoholic fatty liver disease induced by high-fat diet induced through regulating LPS/TLR4 signaling pathway

References

• Chakravarthy MV, Waddell T, Banerjee R, et al. Nutrition and nonalcoholic fatty liver disease: current perspectives. Gastroenterol Clin North Am. 2020;49(1):63–94.
   PubMed Web of Science ®Google Scholar
• Ballestri S, Nascimbeni F, Baldelli E, et al. NAFLD as a sexual dimorphic disease: role of gender and reproductive status in the development and progression of nonalcoholic fatty liver disease and inherent cardiovascular risk. Adv Ther. 2017;34:1291–1326.
   PubMed Web of Science ®Google Scholar
• Irvin MR, Zhi D, Joehanes R, et al. Epigenome-wide association study of fasting blood lipids in the genetics of lipid-lowering drugs and diet network study. Circulation. 2014;130(7):565–572. .
   PubMed Web of Science ®Google Scholar
• Tang XR, Wang JX, Fu L, et al. Effects of total flavonoids in astragali complanati semen on liver lipid level and ERalpha expression on liver in hyperlipidemia rats with kidney-Yang deficiency pattern. Zhongguo Zhong Yao Za Zhi. 2018;43:2365–2371.
   PubMedGoogle Scholar
• Kiziltas S, Ata P, Colak Y, et al. TLR4 gene polymorphism in patients with nonalcoholic fatty liver disease in comparison to healthy controls. Metab Syndr Relat Disord. 2014;12(3):165–170.
   PubMed Web of Science ®Google Scholar
• Miura K, Ohnishi H. Role of gut microbiota and Toll-like receptors in nonalcoholic fatty liver disease. World J Gastroenterol. 2014;20(23):7381–7391.
   PubMed Web of Science ®Google Scholar
• Roh YS, Seki E. Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis. J Gastroenterol Hepatol. 2013;28(Suppl 1):38–42.
   PubMedGoogle Scholar
• Yuan Y, Gong X, Zhang L, et al. Chlorogenic acid ameliorated concanavalin A-induced hepatitis by suppression of Toll-like receptor 4 signaling in mice. Int Immunopharmacol. 2017;44:97–104.
   PubMed Web of Science ®Google Scholar
• Zhang J, Tan YQ, Wei MH, et al. TLR4-induced B7-H1 on keratinocytes negatively regulates CD4+T cells and CD8+T cells responses in oral lichen planus. Exp Dermatol. 2017;26(5):409–415.
   PubMed Web of Science ®Google Scholar
• Plociennikowska A, Hromada-Judycka A, Borzecka K, et al. Co-operation of TLR4 and raft proteins in LPS-induced pro-inflammatory signaling. Cell Mol Life Sci. 2015;72:557–581.
   PubMed Web of Science ®Google Scholar
• Xu Y, Yang C, Zhang S, et al. Ginsenoside Rg1 protects against non-alcoholic fatty liver disease by ameliorating lipid peroxidation, endoplasmic reticulum stress, and inflammasome activation. Biol Pharm Bull. 2018;41(11):1638–1644.
   PubMed Web of Science ®Google Scholar
• Nier A, Huber Y, Labenz C, et al. Adipokines and endotoxemia correlate with hepatic steatosis in non-alcoholic fatty liver disease (NAFLD). Nutrients. 2020;12(3):699.
   Web of Science ®Google Scholar
• Rossato M, Di Vincenzo A, Pagano C, et al. The P2X7 receptor and NLRP3 axis in non-alcoholic fatty liver disease: a brief review. Cells. 2020;9(4):1047.
   Web of Science ®Google Scholar
• Belegri E, Eggels L, la Fleur SE, et al. One-week exposure to a free-choice high-fat high-sugar diet does not interfere with the lipopolysaccharide-induced acute phase response in the hypothalamus of male rats. Front Endocrinol (Lausanne). 2018;9:186.
   PubMed Web of Science ®Google Scholar
• Ding PH, Darveau RP, Wang CY, et al. 3LPS-binding protein and its interactions with P. gingivalis LPS modulate pro-inflammatory response and Toll-like receptor signaling in human oral keratinocytes. PloS One. 2017;12(4):e0173223.
   PubMed Web of Science ®Google Scholar
• Liu Q, Zhu L, Cheng C, et al. Natural active compounds from plant food and Chinese herbal medicine for nonalcoholic fatty liver disease. Curr Pharm Des. 2017;23:5136–5162.
   PubMed Web of Science ®Google Scholar
• Kong L, Wang X, Zhang K, et al. Gypenosides synergistically enhances the anti-tumor effect of 5-fluorouracil on colorectal cancer in vitro and in vivo: a role for oxidative stress-mediated DNA damage and p53 activation. PloS One. 2015;10(9):e0137888.
   PubMed Web of Science ®Google Scholar
• Gou SH, Huang HF, Chen XY, et al. Lipid-lowering, hepatoprotective, and atheroprotective effects of the mixture Hong-Qu and gypenosides in hyperlipidemia with NAFLD rats. J Chin Med Assoc. 2016;79(3):111–121.
   PubMed Web of Science ®Google Scholar
• Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods. 2001;25(4):402–408.
   PubMed Web of Science ®Google Scholar
• Chen Z, Xu YY, Wu R, et al. Impaired learning and memory in rats induced by a high-fat diet: involvement with the imbalance of nesfatin-1 abundance and copine 6 expression. J Neuroendocrinol. 2017;29(4). DOI:10.1111/jne.12462
   Web of Science ®Google Scholar
• Liu Y, Yang X, Jing Y, et al. Contribution and mobilization of mesenchymal stem cells in a mouse model of carbon tetrachloride-induced liver fibrosis. Sci Rep. 2015;5(1):17762. .
   PubMedGoogle Scholar
• Alshammari GM, Balakrishnan A, Chinnasamy T. Nimbolide attenuate the lipid accumulation, oxidative stress and antioxidant in primary hepatocytes. Mol Biol Rep. 2017;44(6):463–474.
   PubMed Web of Science ®Google Scholar
• Elgebaly HA, Mosa NM, Allach M, et al. Olive oil and leaf extract prevent fluoxetine-induced hepatotoxicity by attenuating oxidative stress, inflammation and apoptosis. Biomed Pharmacothe. 2018;98:446–453.
   PubMed Web of Science ®Google Scholar
• Ma C, Kesarwala AH, Eggert T, et al. NAFLD causes selective CD4+ T lymphocyte loss and promotes hepatocarcinogenesis. Nature. 2016;531(7593):253–257. .
   PubMed Web of Science ®Google Scholar
• Henao-Mejia J, Elinav E, Jin C, et al. Inflammasome-mediated dysbiosis regulates progression of NAFLD and obesity. Nature. 2012;482(7384):179–185. .
   PubMed Web of Science ®Google Scholar
• Kim KA, Gu W, Lee IA, et al. High fat diet-induced gut microbiota exacerbates inflammation and obesity in mice via the TLR4 signaling pathway. PloS One. 2012;7(10):e47713.
   PubMed Web of Science ®Google Scholar
• Zhang XQ, Pan Y, Yu CH, et al. PDIA3 knockdown exacerbates free fatty acid-induced hepatocyte steatosis and apoptosis. PloS One. 2015;10(7):e0133882.
   PubMed Web of Science ®Google Scholar
• He Q, Li JK, Li F, et al. Mechanism of action of gypenosides on type 2 diabetes and non-alcoholic fatty liver disease in rats. World J Gastroenterol. 2015;21(7):2058–2066.
   PubMed Web of Science ®Google Scholar
• Lee B, Shim I, Lee H. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and memory impairment in rats. Evid Based Complement Alternat Med. 2018;2018:4183670.
   PubMed Web of Science ®Google Scholar
• Lee B, Shim I, Lee H, et al. Gypenosides attenuate lipopolysaccharide-induced neuroinflammation and anxiety-like behaviors in rats. Animal cells Sys. 2018;22(5):305–316. .
   PubMed Web of Science ®Google Scholar
• Chen Q, Liu M, Yu H, et al. Scutellaria baicalensis regulates FFA metabolism to ameliorate NAFLD through the AMPK-mediated SREBP signaling pathway. J Nat Med. 2018;72:655–666.
   PubMed Web of Science ®Google Scholar
• Liu YL, Lin LC, Tung YT, et al. Rhododendron oldhamii leaf extract improves fatty liver syndrome by increasing lipid oxidation and decreasing the lipogenesis pathway in mice. Int J Med Sci. 2017;14(9):862–870.
   PubMed Web of Science ®Google Scholar